Search results
Results from the WOW.Com Content Network
A single 15 mg dose of mirtazapine to healthy volunteers has been found to result in over 80% occupancy of the H 1 receptor and to induce intense sleepiness. [92] After a short period of chronic treatment, however, the H 1 receptor tends to sensitize and the antihistamine effects become more tolerable. Many patients may also dose at night to ...
A dose of doxepin as low as 1 mg/day was found to significantly improve most of the assessed sleep measures, but unlike the 3 and 6 mg/day doses, was not able to improve wake time during sleep. [12] This, along with greater effect sizes with the higher doses, was likely the basis for the approval of the 3 and 6 mg doses of doxepin for insomnia ...
Testosterone supplementation is also known to reduce the threshold for aggressive behavior in men. [9] The drug is a synthetic androgen and anabolic steroid and hence is an agonist of the androgen receptor (AR), the biological target of androgens like testosterone and dihydrotestosterone (DHT).
30 mg testosterone propionate [1] 60 mg testosterone phenylpropionate [1] 60 mg testosterone isocaproate [1] 100 mg testosterone decanoate [1] Cumulatively, a 1 ml of the oil solution contains exactly 250 mg of above mentioned testosterone esters. [2] [3] This particular numerical value is clearly depicted in the name of the product, Sustanon ...
50–250 mg 1×/2–4 weeks Testosterone undecanoate: Aveed, Nebido: Oil solution: 750–1,000 mg 1×/10–14 weeks Testosterone buciclate a – Aqueous suspension: 600–1,000 mg 1×/12–20 weeks Implant: Testosterone: Testopel: Pellet: 150–1,200 mg/3–6 months Notes: Men produce about 3 to 11 mg of testosterone per day (mean 7 mg/day in ...
Oral MPA has been found to suppress testosterone levels in men by about 30% (from 831 ng/dL to 585 ng/dL) at a dosage of 20 mg/day, by about 45–75% (average 60%; to 150–400 ng/dL) at a dosage of 60 mg/day, [160] [161] [162] and by about 70–75% (from 832 to 862 ng/dL to 214 to 251 ng/dL) at a dosage of 100 mg/day.
Cabergoline requires slow dose titration (2–4 weeks for hyperprolactinemia, often much longer for other conditions) to minimize side effects. The extremely long bioavailability of the medication may complicate dosing regimens during titration and require particular precautions.
[13] [248] [249] (R)-Bicalutamide has a relatively long elimination half-life of 5.8 days with a single dose and 7 to 10 days following repeated administration. [ 8 ] Bicalutamide is eliminated in similar proportions in feces (43%) and urine (34%), while its metabolites are eliminated roughly equally in urine and bile .